|
1.
|
Ku JH, Park YH, Myung JK, Moon KC, Kwak C
and Kim HH: Expression of hypoxia inducible factor-1α and 2α in
conventional renal cell carcinoma with or without sarcomatoid
differentiation. Urol Oncol. 29:731–737. 2011.
|
|
2.
|
Cavalcanti E, Gigante M, Mancini V, et al:
JAK3/STAT5/6 pathway alterations are associated with immune
deviation in CD8 T cells in renal cell carcinoma patients. J Biomed
Biotechnol. 2010:9357642010. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Atkins D, Ferrone S, Schmahl GE, et al:
Down-regulation of HLA class I antigen processing molecules: an
immune escape mechanism of renal cell carcinoma? J Urol.
171:885–889. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Li D, Song L, Fan Y, et al:
Down-regulation of TIPE2 mRNA expression in peripheral blood
mononuclear cells from patients with systemic lupus erythematosus.
Clin Immunol. 133:422–427. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Sun H, Gong S, Carmody RJ, et al: TIPE2, a
negative regulator of innate and adaptive immunity that maintains
immune homeostasis. Cell. 133:415–426. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Luan YY, Yao YM, Zhang L, et al:
Expression of tumor necrosis factor-α induced protein 8 like-2
contributes to the immunosuppressive property of CD4(+)CD25(+)
regulatory T cells in mice. Mol Immunol. 49:219–226. 2011.
|
|
7.
|
Kumar D, Whiteside TL and Kasid U:
Identification of a novel tumor necrosis factor-alpha-inducible
gene SCC-S2, containing the consensus sequence of a death effector
domain of fas-associated death domain-like interleukin-1
beta-converting enzyme-inhibitory protein. J Biol Chem.
275:2973–2978. 2000. View Article : Google Scholar
|
|
8.
|
Horrevoets AJ, Fontijn RD, van Zonneveld
AJ, de Vries CJ, ten Cate JW and Pannekoek H: Vascular endothelial
genes that are responsive to tumor necrosis factor-alpha in vitro
are expressed in atherosclerotic lesions, including inhibitor of
apoptosis protein-1, stannin, and two novel genes. Blood.
93:3418–3431. 1999.
|
|
9.
|
You Z, Ouyang H, Lopatin D, Polver PJ and
Wang CY: Nuclear factor-kappa B inducible death effector
domain-containing protein suppresses tumor necrosis factor-mediated
apoptosis by inhibiting caspase-8 activity. J Biol Chem.
276:26398–26404. 2001. View Article : Google Scholar
|
|
10.
|
Zhang HG, Hyde K, Page GP, et al: Novel
tumor necrosis factor alpha-regulated genes in rheumatoid
arthritis. Arthritis Rheum. 50:420–431. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Zhang S, Zhang Y, Wei X, et al: Expression
and regulation of a novel identified TNFAIP8 family is associated
with diabetic nephropathy. Biochim Biophys Acta. 1802:1078–1086.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Zhang C, Chakravarty D, Sakabe I, et al:
Role of SCC-S2 in experimental metastasis and modulation of
VEGFR-2, MMP-1, and MMP-9 expression. Mol Ther. 13:947–955. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Lee PY, Li Y, Richards HB, et al: Type I
interferon as a novel risk factor for endothelial progenitor cell
depletion and endothelial dysfunction in systemic lupus
erythematosus. Arthritis Rheum. 56:3759–3769. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Ebele JN, Sauter G, Epstein JI and
Sesterhenn IA: Pathology and Genetics of Tumours of the Urinary
System and Male Genital Organs. IARC; Lyon: 2004
|
|
15.
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A III: AJCC Cancer Staging Manual. 2010, 7th
edition. Springer; New York:
|
|
16.
|
Kumar D, Gokhale P, Broustas C,
Chakravarty D, Ahmad I and Kasid U: Expression of SCC-S2, an
antiapoptotic molecule, correlates with enhanced proliferation and
tumorigenicity of MDA-MB 435 cells. Oncogene. 23:612–616. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Patel S, Wang FH, Whiteside TL and Kasid
U: Identification of seven differentially displayed transcripts in
human primary and matched metastatic head and neck squamous cell
carcinoma cell lines: implications in metastasis and/or radiation
response. Oral Oncol. 33:197–203. 1997. View Article : Google Scholar
|
|
18.
|
Yoshinaga-Hirabayashi T and Yoneda Y:
Expression of SCC in ovarian granulosa cells and cultured cells,
induced rapid structural changes in mitochondria. Ital J Anat
Embryol. 106(2 Suppl 1): 51–57. 2001.PubMed/NCBI
|
|
19.
|
Dong QZ, Zhao Y, Liu Y, Wang Y, et al:
Overexpression of SCC-S2 correlates with lymph node metastasis and
poor prognosis in patients with non-small-cell lung cancer. Cancer
Sci. 101:1562–1569. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Zhang X, Wang J, Fan C, et al: Crystal
structure of TIPE2 provides insights into immune homeostasis. Nat
Struct Mol Biol. 16:89–90. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Gus-Brautbar Y, Johnson D, Zhang L, et al:
The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras.
Mol Cell. 45:610–618. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Stark GR, Kerr IM, Williams BR, Silverman
RH and Schreiber RD: How cells respond to interferons. Annu Rev
Biochem. 67:227–264. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Pascual V, Farkas L and Banchereau J:
Systemic lupus erythematosus: all roads lead to type I interferons.
Curr Opin Immunol. 18:676–682. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Koutouzov S, Mathian A and Dalloul A:
Type-I interferons and systemic lupus erythematosus. Autoimmun Rev.
5:554–562. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Hawiger D, Inaba K, Dorsett Y, et al:
Dendritic cells induce peripheral T cell unresponsiveness under
steady state conditions in vivo. J Exp Med. 194:769–779. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Feng X, Wu H, Grossman JM, et al:
Association of increased interferon-inducible gene expression with
disease activity and lupus nephritis in patients with systemic
lupus erythematosus. Arthritis Rheum. 54:2951–2962. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Zhuang H, Narain S, Sobel E, et al:
Association of anti-nucleoprotein autoantibodies with upregulation
of Type I interferon-inducible gene transcripts and dendritic cell
maturation in systemic lupus erythematosus. Clin Immunol.
117:238–250. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Colonna M: TLR pathways and IFN-regulatory
factors: to each its own. Eur J Immunol. 37:306–309. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Honda K, Yanai H, Negishi H, et al: IRF-7
is the master regulator of type-I interferon-dependent immune
responses. Nature. 434:772–777. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Lacunza E, Baudis M, Colussi AG,
Segal-Eiras A, Croce MV and Abba MC: MUC1 oncogene amplification
correlates with protein overexpression in invasive breast carcinoma
cells. Cancer Genet Cytogenet. 201:102–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
